- An interview with Dr. Harold Varmus marks the 40th anniversary of the National Cancer Act.
- The carcinogenic role of HPV in lung cancer is being studied in France.
- ATM gene mutations increase risk for hereditary pancreatic cancer.
- Emory University researchers study cancer cells’ need for glucose.
- Ohio State study demonstrates how normal cells can promote tumor growth after loss of the tumor suppressor gene Pten.
Category Archives: In the News
Blog Buzz: December 17 – December 22
The blogs are abuzz with the sound of…
- Recent studies found patients want access to their doctor’s notes. Shots, NPR’s Health Blog, has this coverage of the story, and here is iHealthBeat’s take.
- ‘Tis the season for year-end lists, such as the PNAS‘ Top Stories of 2011, The Scientist’s Top Science Scandals of 2011, and ASCO’s report on Clinical Cancer Advances for 2011.
- Along those lines, Laika’s MedLibLog has an interesting post about the latest version of Jeffery Beall’s List of Predatory, Open-Access Publishers, 2012 Edition.
- The Scholarly Communications Update from Becker Medical Library mentions last week’s article proposing a “twimpact” factor where analysis of tweets predicted highly cited articles.
- ScienceInsider writes that, in response to a request made by a US government biosecurity advisory board, Grudgingly, Virologists Agree to Redact Details of Sensitive Flu Papers. Over at NatureNews, scientists call for stricter controls as as Fears Grow Over Lab Bred Flu.
Cancer Research News: December 7 – December 20
- A study of two sisters provides new insight into lymphoma development.
- The New Mexico’s Women’s Health Study provides evidence that breast cancer mortality is higher in Hispanic women.
- The Institute of Medicine issued a report on environmental factors and the risk of breast cancer.
- The National Human Genome Research Institute (NHGRI) released a new funding plan that includes a gradual reduction in the base funding for the large-scale sequencing centers.
- A potential blood test for colorectal cancer has been developed by ARUP Laboratories.